Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu-Reference-Cited by-同舟云学术

Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu

Published:2020-09 Issue: Volume:113 Page:102469
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Zhang Dongdong,Kinloch Andrew J.,Srinath Abhinav,Shenkar Robert^ORCID,Girard Romuald,Lightle Rhonda,Moore Thomas,Koskimäki Janne,Mohsin Azam,Carrión-Penagos Julián,Romanos Sharbel,Shen Le,Clark Marcus R.,Shi Changbin,Awad Issam A.

Funder

National Institutes of Health

National Center for Advancing Translational Sciences

University of Chicago

National Natural Science Foundation of China

Natural Science Foundation of Heilongjiang Province

Ministry of Human Resources and Social Security

Maud Kuistila Foundation

Emil Aaltonen Foundation

NCI

Comprehensive Cancer Center

NIH

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Cavernous angiomas: deconstructing a neurosurgical disease;Awad;J. Neurosurg.,2019

2. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations;Clatterbuck;J. Neurol. Neurosurg. Psychiatry,2001

3. Ultrastructural analysis of vascular features in cerebral cavernous malformations;Tanriover;Clin. Neurol. Neurosurg.,2013

4. Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations;Tu;J. Neurosurg.,2005

5. Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations;Shenkar;Neurosurgery,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRIT1 in vascular biology and beyond;Bioscience Reports;2024-07

2. Infratentorial Cerebral Cavernous Malformation May be a Risk Factor for Symptomatic Bleeding and Precocity of Symptoms: A Multicenter, Propensity Score Matched, Case-Control Study;Current Neurovascular Research;2024-05

3. Transcriptomic signatures of individual cell types in cerebral cavernous malformation;Cell Communication and Signaling;2024-01-09

4. Corrigendum to “Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu” [J. Autoimmun. 113 (2020) 102469];Journal of Autoimmunity;2023-11

5. Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation;Brain Sciences;2023-09-17